Mr. Travis Doupe reports

WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS

Willow Biosciences Inc. has released the voting results from its annual general and special meeting of shareholders held on April 25, 2025. A total of 59,214,893 common shares, representing approximately 40.88 per cent of the company's issued and outstanding shares, were represented at the meeting.

The shareholders approved the setting of the number of directors of Willow at five directors, and the following nominees were elected as directors of Willow for the ensuing year with the specific voting results being as follows.

In addition, shareholders approved the below matters. The resolutions approving the below matters may be viewed in full in the company's management information circular dated March 26, 2025.

For complete voting results on all matters approved at the meeting, please see the company's report of voting results dated April 25, 2025, available on SEDAR+.

About Willow Biosciences Inc.

Willow develops and produces precision fermented functional ingredients for the health and wellness, food and beverage, and personal care markets. Willow's FutureGrown biotechnology platform allows large-scale production with sustainability at its core. Willow's research and development team has a proven record of developing and commercializing bio-based manufacturing processes and products to benefit its business-to-business partners and their customers.